Related Experiment Video
Updated: Jan 27, 2026

08:31
Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
Published on: September 12, 2025
793
Intravascular Lymphoma Presenting as a Cavernous Sinus Tumor
Shigeru Kawai1, Takeshi Okuda2, Ayano Fukui3
1Department of Neurology, Kindai University Faculty of Medicine, Japan.
Internal Medicine (Tokyo, Japan)
|March 29, 2019
Summary
Intravascular lymphoma (IVL), a rare cancer, can form tumors within blood vessels. This study details a unique case where IVL mimicked a cavernous sinus tumor, restricting eye movement.
Area of Science:
- Oncology
- Hematology
- Ophthalmology
Background:
- Intravascular lymphoma (IVL) is a rare hematologic malignancy characterized by the proliferation of malignant lymphocytes within blood vessels.
- Atypical presentation of IVL can pose diagnostic challenges, potentially mimicking other space-occupying lesions.
Observation:
- A patient presented with restricted eye movement, clinically suggestive of a cavernous sinus tumor.
- Imaging revealed a mass within the cavernous sinus, extending contralaterally.
Findings:
- Histopathological examination confirmed the mass to be intravascular lymphoma (IVL).
- The unique anatomical structure of the cavernous sinus, with its multiple compartments, facilitated the trapping and accumulation of IVL cells, leading to mass formation.
- Tumor cells spread via intercavernous sinuses to the contralateral cavernous sinus.
Implications:
- This case highlights the importance of considering IVL in the differential diagnosis of cavernous sinus masses, especially when presenting with ophthalmoplegia.
- Understanding the mechanisms of IVL tumor cell trapping within the complex venous architecture of the cavernous sinus is crucial for diagnosis and treatment.
- The findings underscore the potential for IVL to manifest as a localized mass lesion rather than diffuse infiltration.
Related Concept Videos
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias
811
Arrhythmias are disturbances in the heart's rhythm that lead to abnormal heartbeats. These irregularities can originate from different parts of the heart and are classified based on their origin and nature.
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
811
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Tumor Progression
7.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.3K
The Tumor Microenvironment
7.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.7K
Loss of Tumor Suppressor Gene Functions
5.9K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.9K
Cancer Stem Cells and Tumor Maintenance
5.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K

